Control group:Dual therapy of rivaroxaban (15 mg, once/d) + clopidogrel (75 mg, once/d) to 6 months after PCI

A multi-center, randomized controlled clinical evaluation study of Naoxintong Capsules for improving the quality of life of patients with non-valvular atrial fibrillation after PCI

Clinical Evaluation of Naoxintong Capsule for Improving the Quality of Life of Patients with Nonvalvular Atrial Fibrillation after PCI